Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rafii

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 9, 2026
Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 TrialSonal Sukreet, Michael C Donohue, Jennifer Ngolab, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A Rissman, Oliver Langford, Rema Raman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Brain Communications|June 15, 2026
Immunosuppression in down syndrome regression disorder: a prospective observational cohort studyJonathan D Santoro, Lilia Kazerooni, Maeve C Lucas, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
JAMA Neurology|May 9, 2022
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical TrialMichael S Rafii, Olivier Sol, William C Mobley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Nature|May 13, 2026
Sleep chart of biological ageing clocks in middle and late life, Cliodhna Kate O'Toole, Zhiyuan Song, et al.
Brain : a Journal of Neurology|November 8, 2025
Imaging and plasma biomarkers for pathological accumulation in Down syndromeJulie K Wisch, Ziqiao Jiao, James T Kennedy, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 9, 2026
Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 TrialSonal Sukreet, Michael C Donohue, Jennifer Ngolab, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's diseaseRobert A Rissman, Oliver Langford, Rema Raman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Brain Communications|June 15, 2026
Immunosuppression in down syndrome regression disorder: a prospective observational cohort studyJonathan D Santoro, Lilia Kazerooni, Maeve C Lucas, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
JAMA Neurology|May 9, 2022
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical TrialMichael S Rafii, Olivier Sol, William C Mobley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 3, 2017
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's diseaseMaría Carmona-Iragui, Mircea Balasa, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
Nature|May 13, 2026
Sleep chart of biological ageing clocks in middle and late life, Cliodhna Kate O'Toole, Zhiyuan Song, et al.
Brain : a Journal of Neurology|November 8, 2025
Imaging and plasma biomarkers for pathological accumulation in Down syndromeJulie K Wisch, Ziqiao Jiao, James T Kennedy, et al.
Pageof 22